2028, Compounding and Diabetes

Innovating small molecule injectables: market forecast to 2033

European Pharmaceutical Review

JUNE 5, 2024

billion in 2028. As such, the compound annual growth rate (CAGR) is expected to be 12.8 million deaths from diabetes” worldwide. A report by the Business Research Company predicts that the small molecule injectable drugs market will value $355.14 percent up to this period. million deaths from cardiovascular diseases, 9.3

Compounding

Compounding Diabetes

Neurology remains key therapeutic area for Japan pharma majors: GlobalData

Express Pharma

MAY 30, 2024

million in 2023 to 9 million in 2028. In the APAC region, several factors contribute to the increasing prevalence of neurological disorders, including ageing populations, lifestyle changes, and the rising incidence of risk factors such as hypertension and diabetes.” billion in 2030, with a compound annual growth rate (CAGR) of 117.6

Compounding

Compounding Diabetes Pharmaceutical Companies Pharmaceutical Companies

Pharmacist Digest

Innovating small molecule injectables: market forecast to 2033

Neurology remains key therapeutic area for Japan pharma majors: GlobalData

Webinars

Stay Connected